156 (39%) had CD4 counts below 350 cells/mm3 indicating eligibility for antiretroviral treatment if pregnant, co-infected with tuberculosis or in WHO clinical state IV according to the South African guidelines at the time period during which the study took place (September 2010– March 2011) [20]. This evidence concerns the gene CD4 and tuberculosis.